Global Patent Index - EP 1235841 A4

EP 1235841 A4 20060412 - INDUCING CELLULAR IMMUNE RESPONSES TO MAGE2/3 USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS

Title (en)

INDUCING CELLULAR IMMUNE RESPONSES TO MAGE2/3 USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS

Title (de)

INDUZIERUNG VON ZELLULÄRER IMMUNANTWORT AUF MAGE2/3 MIT HILFE VON PEPTID- UND NUKLEINSÄUREZUBEREITUNGEN

Title (fr)

DECLENCHEMENT DE REPONSES IMMUNITAIRES CELLULAIRES A MAGE2/3 AU MOYEN DE COMPOSITIONS DE PEPTIDES ET D'ACIDES NUCLEIQUES

Publication

EP 1235841 A4 20060412 (EN)

Application

EP 00984183 A 20001211

Priority

  • US 0033545 W 20001211
  • US 45829899 A 19991210

Abstract (en)

[origin: WO0142267A1] The invention uses our knowledge of the mechanisms by which antigen is recognized by T cells to identify and prepare MAGE2/3 epitopes, and to develop epitope-based vaccines directed towards MAGE2/3-bearing tumors. More specifically, this application communicates our discovery of pharmaceutical compositions and methods of use in the prevention and treatment of cancer.

IPC 1-7

C07H 21/02; C07H 21/04; C07H 21/00; A61K 38/04; A61K 35/08; A61K 38/10; A61K 38/16; A61K 39/00; A61K 48/00; C07K 9/00; C07K 7/00; C07K 11/00

IPC 8 full level

C12N 15/09 (2006.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01); A61P 37/04 (2006.01); A61P 43/00 (2006.01); C07K 14/47 (2006.01)

CPC (source: EP US)

A61K 39/001186 (2018.07 - US); A61K 39/4615 (2023.05 - EP); A61K 39/4622 (2023.05 - EP); A61K 39/464486 (2023.05 - EP); A61P 35/00 (2017.12 - EP); A61P 37/04 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07K 14/4748 (2013.01 - EP); A61K 2039/53 (2013.01 - EP); A61K 2039/6031 (2013.01 - EP); C07K 2319/00 (2013.01 - EP)

Citation (search report)

  • [X] WO 9945954 A1 19990916 - EPIMMUNE INC [US]
  • [X] WO 9713858 A2 19970417 - CHIRON CORP [US], et al
  • [X] WO 9522317 A1 19950824 - CYTEL CORP [US]
  • [AD] US 5662907 A 19970902 - KUBO RALPH T [US], et al
  • [A] DEL GUERCIO M-F ET AL: "Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T Helper Epitopes (PADRE) for antibody responses in vivo", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 15, no. 4, March 1997 (1997-03-01), pages 441 - 448, XP004094438, ISSN: 0264-410X
  • [A] ALTMAN J ET AL: "Phenotypic analysis of antigen-specific T lymphocytes", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, vol. 274, no. 5284, 4 October 1996 (1996-10-04), pages 94 - 96, XP002135711, ISSN: 0036-8075
  • See references of WO 0142267A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

DOCDB simple family (publication)

WO 0142267 A1 20010614; AU 2085001 A 20010618; CA 2393339 A1 20010614; EP 1235841 A1 20020904; EP 1235841 A4 20060412; JP 2003517310 A 20030527

DOCDB simple family (application)

US 0033545 W 20001211; AU 2085001 A 20001211; CA 2393339 A 20001211; EP 00984183 A 20001211; JP 2001543564 A 20001211